Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe ...

In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...

Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...

Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative ...

Organizers said they hope to empower seniors to improve balance, alleviate pain and stiffness and increase confidence.

(Nasdaq: AMRX) ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules ...

President Donald Trump said Friday he is “strongly considering” levying new sanctions and tariffs on Russia for its war ...

University Hospital Southampton acquires M3DIMAKER 3D printer from FABRX - enabling further research into personalized medicine.

Namenda (memantine) is the only drug in this class, and it is approved for moderate to severe Alzheimer's. Namenda appears to work by regulating levels of glutamate, an amino acid, in the brain.